Purchase Order 75N92E19P00078
Award Date 3/11/19
Potential Completion Date 4/30/19
Potential Value $11K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Grand Island, NY 14072, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation on March 30, 2020, with a ceiling value of $17,280.00 for firm fixed-price commercial supplies. Place of performance is Grand Island, New York. The order was scheduled for ultimate completion on July 25, 2020. No set-aside was used. Life Technologies, a subsidiary of Thermo Fisher Scientific, is a leading supplier of biomedical research tools, genetic analysis instruments, reagents, and...
- The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation for $10,083.10 on March 29, 2018, with completion by April 27, 2018. Performance occurs in Bethesda, Maryland. The order is priced firm fixed price with no small business set-aside. Specific requirements are not detailed in the source. Life Technologies, operating as Thermo Fisher Scientific, manufactures laboratory instrumentation and reagents; the company competes full and open across federal...
- The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $5,172.00 on August 10, 2018, with an ultimate completion date of September 9, 2018. Performance occurs in North Bethesda, Maryland. The order is priced firm fixed price with no set-aside category applied. Life Technologies Corporation operates as a subsidiary of Thermo Fisher Scientific Inc. and supplies laboratory instrumentation, reagents, and consumables to federal research and...
- <p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $4,995.00 on August 17, 2018, with completion targeted for October 18, 2018. Place of performance is North Bethesda, Maryland. The order is firm fixed price for laboratory consumables or instrumentation supplied by Life Technologies, a for-profit manufacturer and supplier of laboratory instrumentation, reagents, and consumables operating as Thermo Fisher Scientific.</p>
- <p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation for $12,187.66 on August 21, 2020, for genotyping experiments. Performance is at Life Technologies' facility in Grand Island, New York. The order carries a firm fixed price and has an ultimate completion date of October 30, 2020. No set-aside category applies.</p>
- The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation on August 10, 2019, for $22,278.60, with an ultimate completion date of October 31, 2019. Performance occurs in Bethesda, Maryland. The order is priced on a firm fixed price basis with no set-aside category. Life Technologies supplies laboratory instrumentation, reagents, and consumables to federal research and health agencies; the source does not specify the particular items or quantities...
- The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $16,278.92 on August 24, 2017, for an ultimate completion date of March 2, 2018. Place of performance is Bethesda, Maryland. The order is for firm fixed price commercial laboratory supplies and equipment. No set-aside was used. Life Technologies, operating as Thermo Fisher Scientific, supplies biotechnology instrumentation, reagents, and consumables to federal research and health...
- <p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $18,551.24 on January 30, 2018, with an ultimate completion date of February 21, 2019. The order covers laboratory instrumentation, reagents, and consumables. Place of performance is Bethesda, Maryland. The contract carries firm fixed price and no small business set-aside designation.</p>
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $25,000 firm fixed price purchase order to Life Technologies Corporation for various biological reagents from Thermo Fisher Scientific. Life Technologies Corporation is a subsidiary of Thermo Electron Corporation Financial Services Division. The contract has a period of performance from September 1, 2023 through April 30, 2024 and will be performed by Life Technologies...
- <p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation for $14,716.35 on March 15, 2019, for reagents and kits, with completion by April 15, 2019. Place of performance is Carlsbad, California. The order carries no set-aside designation and is priced on a firm fixed price basis.</p>
The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation on March 11, 2019, valued at $11,095.74 for reagents and kits. Place of performance is Grand Island, New York. The order carries a firm fixed price and ultimate completion date of April 30, 2019. Life Technologies Corporation, a wholly owned subsidiary of Thermo Fisher Scientific Inc., is a large business with no small business set-asides, competing on proprietary biomedical research instrumentation and specialized scientific capabilities across federal health and research agencies.
Generated 8/1/26, 9:48 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 3/10/19 |